Brain ischemic injury in rodents: the protective effect of EPO

Annelise Letourneur1, Edwige Petit, Simon Roussel

  • 1CERVOxy team "Hypoxia, cerebrovascular and tumoral pathophysiologies", UMR 6301-ISTCT, CNRS, CEA, Université de Caen Basse-Normandie, CYCERON, Caen, France.

Insights

This study details methods for inducing transient and permanent cerebral ischemia in rodents. These animal models are crucial for evaluating therapeutic strategies for stroke, including drugs like erythropoietin (EPO).

Area of Science:

  • Neuroscience
  • Pathology
  • Pharmacology

Background:

  • Animal models are essential for studying human diseases.
  • Cerebral ischemia, or stroke, requires reliable models for research.
  • Evaluating therapeutic interventions necessitates robust preclinical models.

Purpose of the Study:

  • To describe procedures for inducing transient and permanent cerebral ischemia in mice and rats.
  • To highlight the utility of these models for assessing therapeutic strategies.
  • To provide a foundation for research on stroke treatments.

Main Methods:

  • Transient middle cerebral artery occlusion (MCAO) induced by filament insertion.
  • Permanent MCAO achieved through distal electrocoagulation in mice.
  • Assessment of therapeutic efficacy includes tissue analysis, behavioral, and cognitive evaluations.

Main Results:

  • Established reproducible methods for inducing cerebral ischemia in rodent models.
  • Demonstrated the models' capacity to evaluate treatment effectiveness from cellular to behavioral levels.
  • Highlighted the models' extensive use in evaluating drugs like erythropoietin (EPO).

Conclusions:

  • The described rodent models of cerebral ischemia are valuable tools for preclinical research.
  • These models facilitate the comprehensive evaluation of potential stroke therapies.
  • Further research utilizing these models can advance the development of treatments for cerebral ischemia.

Related Concept Videos